Together, these results indicate that calcitriol suppresses AKT signaling in HER2-positive breast cancer cells, thereby potentially enhancing the antiproliferative efficacy of antiestrogens and tyrosine kinase inhibitors. This evidence concerns the gene ERBB2 and breast carcinoma.